alendronate has been researched along with Acquired Hyperostosis Syndrome in 3 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Acquired Hyperostosis Syndrome: Syndrome consisting of SYNOVITIS; ACNE CONGLOBATA; PALMOPLANTAR PUSTULOSIS; HYPEROSTOSIS; and OSTEITIS. The most common site of the disease is the upper anterior chest wall, characterized by predominantly osteosclerotic lesions, hyperostosis, and arthritis of the adjacent joints. The association of sterile inflammatory bone lesions and neutrophilic skin eruptions is indicative of this syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fioravanti, A | 1 |
| Cantarini, L | 1 |
| Burroni, L | 1 |
| Mazzei, MA | 1 |
| Volterrani, L | 1 |
| Galeazzi, M | 1 |
| Zhang, LL | 1 |
| Zhao, JX | 1 |
| Liu, XY | 1 |
| Witzig, M | 1 |
| Bützberger, S | 1 |
| Caravatti, M | 1 |
| Furrer, J | 1 |
| Schulthess, G | 1 |
3 other studies available for alendronate and Acquired Hyperostosis Syndrome
| Article | Year |
|---|---|
Efficacy of alendronate in the treatment of the SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Adult; Alendronate; Bone Density Conservation Agents; Female; Humans | 2008 |
Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study.
Topics: Acquired Hyperostosis Syndrome; Alendronate; Antirheumatic Agents; Bone Density Conservation Agents; | 2012 |
[Backache and palmar eczema (SAPHO syndrome)].
Topics: Acquired Hyperostosis Syndrome; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Dia | 2003 |